Skip to content

A study to characterize access to specialty care received by American Indians/Alaska Natives (CATORI)

Study to characterize access to specialty care received by American Indians/Alaska Natives (CATORI)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN58893554
Enrollment
150
Registered
2022-10-11
Start date
2022-10-14
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Participants requiring referral to specialty care (neurology, ophthalmology, oncology) Not Applicable

Interventions

Participants who self-identify as American Indian or Alaska Native with any indication requiring referral to a specialist (neurologist, ophthalmologist, and oncologist) after a PCP standard of care vi

Sponsors

Genentech, Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or more 2. Ability to read English at 8th grade proficiency or have a household member willing to assist in translation to complete patient surveys 3. Self-identification as American Indian or Alaska Native 4. Referred to an oncologist, neurologist, or ophthalmologist for the first time 5. Personal landline or cell phone and/or access to internet 6. Willingness to complete all surveys in the study and participate for 12 months

Exclusion criteria

Exclusion criteria: 1. Currently under the care of a specialist (>3 months) to whom they are being referred to by the PCP (i.e., to be eligible, the specialty care physician should be new to the participant) 2. Currently or planned to receive care that requires in participant visits for the indication requiring referral from the PCP (e.g., radiotherapy, chemotherapy for cancer diagnosis) within 3 months of consent date

Design outcomes

Primary

MeasureTime frame
Percentage of AI/AN participants seen by a specialist for advanced care after PCP referral to a specialist assessed using data collected in electronic case report forms (eCRF) at Months 6 and 12

Secondary

MeasureTime frame
1. Percentage of participants seen by a specialist and treated for their disease assessed using data collected in eCRF at Months 6 and 12 2. Participant reported barriers to specialty referral completion assessed using data collected from surveys at Months 6 and 12

Countries

United States of America

Contacts

Public ContactClinical Trials
global-roche-genentech-trials@gene.com+1 888-662-6728

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026